Navigation Links
Shire Provides Update on ProAmatine® (midodrine HCl)
Date:9/22/2011

PHILADELPHIA, Sept. 22, 2011 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces an update on the approval status and availability of ProAmatine® (midodrine HCl), a medicine approved for the treatment of symptomatic orthostatic hypotension (SOH).  Shire has engaged in consistent dialogue with the U.S. Food and Drug Administration (FDA) for the past 12 months in the hopes of either securing final FDA approval of this medicine based on the data submitted following two post-marketing clinical trials, or establishing an agreed development plan for conducting additional clinical trials.

ProAmatine remains available to patients today as discussions between FDA and Shire continue concerning the status of its NDA.  Shire, the NDA holder for ProAmatine, remains committed to ensuring midodrine remains available for patients who critically need this medicine and who would be left without alternative treatments should it be withdrawn from the market."While we continue to work with the FDA to design trials that further confirm the clinical efficacy of ProAmatine, we've reached an impasse and we now believe the fastest way to get the final approval for this medicine is to present our data at a public hearing, thereby sparing patients the additional hardships of clinical trials," said Jeffrey Jonas, M.D., Senior Vice President of Research & Development for Shire.  "This is a unique situation and we're doing everything we can to keep this medicine on the market so patients can continue to access it."

ProAmatine was approved in 1996 under Subpart H (an accelerated approval process) for the treatment of SOH, with a post-approval commitment to conduct two clinical trials to verify the clinical effect of midodrine.  The initial approval was based on ProAmatine's demonstrated ability to significantly
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... /PRNewswire-iReach/ -- Dr. Michael Gabriel of a prominent ... a recent study, which shows how grief in pregnancy may ... According to US News , ... likely than others to grow up overweight or obese, even ... were two specific types of stress that caused obesity: "Children ...
(Date:7/24/2014)... 24, 2014  Parnell Pharmaceuticals Holdings Ltd announces ... be added to Parnell,s already extensive pipeline through ... a biotechnology company. The compounds now known as ... in bone regeneration and dermal regeneration, respectively. Parnell ... for the veterinary market with the potential to ...
(Date:7/24/2014)... Wis. , July 24, 2014  Restore ... specialty and compounded pharmaceuticals, announced that it is ... information unique to each individual based upon their ... possible by understanding the interaction between a patient,s ... "We,re very excited to provide this new ...
Breaking Medicine Technology:Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3
... Neuralstem, Inc. (NYSE Amex: CUR ) updated the ... the company,s spinal cord stem cells in the treatment of ... University in Atlanta, Georgia. The company announced that, after reviewing the ... Monitoring Board has unanimously approved moving to the last group ...
... Science Corporation , a global leader in automated external defibrillator ... has been awarded a contract to deploy Powerheart® AEDs at ... Postal Inspection Service is the primary law enforcement arm of ... to have been selected to protect the men and women ...
Cached Medicine Technology:Neuralstem Updates ALS Clinical Trial Progress 2Neuralstem Updates ALS Clinical Trial Progress 3Neuralstem Updates ALS Clinical Trial Progress 4U.S. Postal Inspection Service Awards AED Contract to Cardiac Science 2U.S. Postal Inspection Service Awards AED Contract to Cardiac Science 3U.S. Postal Inspection Service Awards AED Contract to Cardiac Science 4
(Date:7/25/2014)... July 24, 2014 (HealthDay News) -- Women who compete ... disorders, including incontinence, and other health problems, a new ... popularity of high-impact sports such as triathlons, but little ... pelvic health and certain other issues associated with endurance ... physiatrist at Loyola University Health System, said in a ...
(Date:7/25/2014)... initial romantic encounters determine the fate of a potential ... necessary to fuel sexual desire and land a second ... for both men and women on a first date. ... Do men perceive responsive women as more attractive, and ... men? A study published in Personality and Social ...
(Date:7/25/2014)... 25, 2014 The Futon Shop ... Futon Sale. The Futon Shop has been around since 1976 ... has grown from a few handmade futon mattresses a month, ... of futon mattresses. , The Futon Shop futon mattresses ... the desire to sleep on natural fibers was a growing ...
(Date:7/25/2014)... July 25, 2014 Stwd.co.uk, one of ... new collection of cheap evening dress for ... launch a big promotion for these items. They are ... promotion will last until August 30. , “We are ... Beside evening outfits, we have a large number of ...
(Date:7/25/2014)... Mirada (PRWEB) July 25, 2014 ... La Mirada clinic is offering Occupational Medicine ... Center is happily accepting referrals and workers’ compensation ... the La Mirada clinic include wound care treatment ... and ergonomic assessments, pre-employment screening & physicals, and ...
Breaking Medicine News(10 mins):Health News:Female Triathletes May Face Health Problems Such as Incontinence 2Health News:Why do men prefer nice women? 2Health News:Why do men prefer nice women? 3Health News:Organic Mattress Manufacturer Celebrates 38 Years Of Being In Business 2Health News:Organic Mattress Manufacturer Celebrates 38 Years Of Being In Business 3Health News:Famous Supplier Stwd.co.uk Announces Its New Selection of Evening Dresses for Women 2Health News:Healthpointe Offering Occupational Medicine Services in La Mirada 2
... of deep concern and disappointment about reports that the ... issues that are critical to access to care for ... the American College of Physicians (ACP). David C. ... behalf of the 124,000 internal medicine physicians and medical ...
... Supplier, WAKEFIELD, Mass., Sept. 21 Friends ... research and programs,today announced that it is recalling ... to donors who contribute to its cancer-related programs. ... supplier that the,bracelets did not contain lead. When ...
... and treatments to save dogs,from cancer and the benefits ... subject of a news report that debuted on ABC ... picked up by about 15,stations nationwide, detailed the innovative ... the University of California-Davis and,being funded and supported by ...
... is a,statement by Robert Greenstein, executive director of ... new congressional SCHIP agreement:, "Today,s agreement would ... a major accomplishment. Contrary to White,House rhetoric, the ... are poor,and near-poor children who are uninsured, not ...
... patients with incurable disease fared better, doctor says , FRIDAY, ... tumors may help improve treatment for some patients with incurable ... president of Oncology Care Associates in St. Joseph, Mich., had ... drugs might offer them the most benefit, Lester used DNA ...
... 20 -- A new study led by investigators from the ... of necrosis, long thought to be a chaotic, irreversible pathway ... a regulated response to stress by a powerful protein, SRP-6, ... research team realized that this protein might be harnessed to ...
Cached Medicine News:Health News:'Deep concern and disappointment' with exclusion of Medicare from SCHIP legislation 2Health News:'Deep concern and disappointment' with exclusion of Medicare from SCHIP legislation 3Health News:Friends of Mel Announce Recall of Jewelry Due to Lead 2Health News:Friends of Mel Announce Recall of Jewelry Due to Lead 3Health News:ABC TV San Francisco Features Canine Cancer Research Story: Saving Our Dogs, Helping Humans Beat Cancer - Work at Morris Animal Foundation, UC-Davis 2Health News:Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement 2Health News:Pathway to cell death redefined in landmark study 2Health News:Pathway to cell death redefined in landmark study 3Health News:Pathway to cell death redefined in landmark study 4
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTC/1Q chairs are recommended for the ... room, static control, health care and ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... are recommended for the following environments: ... control, health care and office. • ...
... Basic ergonomic chairs with ... with lumbar support • Select ... and casters and glides. • ... the following environments: industry, education, ...
Medicine Products: